Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

20.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climatic reconstruction at the Miocene Shanwang basin, China, using leaf margin analysis, CLAMP, coexistence approach, and overlapping distribution analysis.

American journal of botany·2011
Same author

Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

Endocrine-related cancer·2011
Same author

Stress and strain analysis of contractions during ramp distension in partially obstructed guinea pig jejunal segments.

Journal of biomechanics·2011
Same author

Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Hypertension research : official journal of the Japanese Society of Hypertension·2011
Same author

Transarticular screw and C1 hook fixation for os odontoideum with atlantoaxial dislocation.

World neurosurgery·2011
Same author

Surgical treatments of myelopathy caused by cervical ligamentum flavum ossification.

World neurosurgery·2011

Related Experiment Video

Updated: Apr 25, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

7.8K

Microribonucleic acids and vascular restenosis.

Zhi-Xing Fan1, Jian Yang

  • 1Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China. E-mail. 942686648@qq.com.

Saudi Medical Journal
|August 18, 2014
PubMed
Summary

Microribonucleic acids (miRNAs) regulate cellular functions and their abnormal expression is linked to cardiovascular diseases. This review explores vascular-specific miRNAs in restenosis, focusing on smooth muscle cell proliferation and migration, and discusses miRNA-based therapies.

More Related Videos

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

5.3K
Development of a Murine Model for Femoral Artery Anastomotic Stenosis
05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

789

Related Experiment Videos

Last Updated: Apr 25, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

7.8K
A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

5.3K
Development of a Murine Model for Femoral Artery Anastomotic Stenosis
05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

789

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Microribonucleic acids (miRNAs) are small non-coding RNAs regulating gene expression.
  • Aberrant miRNA expression is implicated in human diseases, notably cardiovascular dysfunction.
  • Vascular restenosis is a significant complication following vascular interventions.

Purpose of the Study:

  • To review the identification and roles of vascular-specific miRNAs in vascular restenosis.
  • To elucidate the mechanisms by which miRNAs influence vascular smooth muscle cell proliferation and migration.
  • To discuss the potential of miRNA-based therapeutic strategies for vascular restenosis.

Main Methods:

  • Literature review of recent studies on miRNAs in vascular biology.
  • Analysis of mechanisms underlying miRNA regulation of vascular smooth muscle cells.
  • Summary of current and emerging miRNA-based drug and gene therapies.

Main Results:

  • Vascular-specific miRNAs play critical roles in the pathogenesis of vascular restenosis.
  • miRNAs modulate vascular smooth muscle cell proliferation and migration, key processes in restenosis.
  • miRNA expression profiles offer potential diagnostic and therapeutic targets.

Conclusions:

  • Vascular-specific miRNAs are crucial regulators in vascular restenosis.
  • Targeting miRNAs presents a promising avenue for novel therapeutic interventions.
  • Further research into miRNA mechanisms and delivery systems is warranted for clinical application.